Key Events This Week
15 Jun: Stock opens strong at ₹24.17, up 6.24%
16 Jun: Technical momentum shifts; Mojo Grade upgraded to Hold
17 Jun: Mild bullish technical outlook confirmed with 4.72% gain
18-19 Jun: Minor corrections amid mixed volume and market volatility

Mukka Proteins Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials
2026-06-17 08:37:56Mukka Proteins Ltd, a micro-cap player in the FMCG sector, has seen its investment rating upgraded from Sell to Hold as of 16 June 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, and recent financial trends. Despite lingering concerns over long-term fundamentals, the stock’s recent performance and market positioning have prompted a reassessment by analysts.
Read full news article
Mukka Proteins Ltd Technical Momentum Shifts Signal Mild Bullish Outlook
2026-06-17 08:06:50Mukka Proteins Ltd, a micro-cap player in the FMCG sector, has witnessed a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by improvements in key indicators such as the MACD and Bollinger Bands on the weekly chart, alongside a recent upgrade in its MarketsMOJO grade from Sell to Hold, signalling cautious optimism among investors.
Read full news article
Mukka Proteins Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-06-16 08:07:52Mukka Proteins Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a strong day gain of 6.24%, the micro-cap FMCG stock remains under pressure with a Mojo Grade of Sell, signalling cautious investor sentiment amid mixed market cues.
Read full news article
Mukka Proteins Ltd is Rated Sell by MarketsMOJO
2026-06-09 10:10:44Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Mukka Proteins Ltd is Rated Sell
2026-05-28 10:10:30Mukka Proteins Ltd is rated Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Mukka Proteins Ltd is Rated Sell by MarketsMOJO
2026-05-17 10:10:27Mukka Proteins Ltd is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's present condition as of 17 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news articleAre Mukka Proteins Ltd latest results good or bad?
2026-05-16 19:31:30Mukka Proteins Ltd's latest financial results for Q4 FY26 present a complex picture of the company's performance. The net sales for the quarter were reported at ₹380.61 crores, reflecting a significant quarter-on-quarter decline of 41.76% from the previous quarter's exceptional sales of ₹653.50 crores. Year-on-year, net sales saw a marginal contraction of 0.25%, indicating stagnation in core operations amidst notable volatility in revenue generation over recent quarters. Despite the revenue challenges, Mukka Proteins reported a consolidated net profit of ₹20.62 crores for Q4 FY26, which represents a year-on-year increase of 51.73%. However, this figure also reflects a quarter-on-quarter decline of 13.18%. The operating profit margin, excluding other income, improved to 9.21% from 7.84% in the same quarter last year, suggesting better cost management. Nevertheless, the company's reliance on non-operating in...
Read full news article






